CARLSBAD, Calif., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that it will showcase its new spinal fixation system, Arsenal as well as its comprehensive portfolio of products at the upcoming North American Spine Society (NASS) meeting at the Moscone Convention Center in San Francisco, California, which will be held from November 12th – 14th, 2014. Alphatec Spine will be located in booth number 829.
This year Alphatec is pleased to host the following events at NASS:
Alphatec Spinal Fusion Technologies Technical Exhibit Booth #829: Alphatec will be showcasing its broad portfolio of spinal fusion products, including Arsenal, its newest and most innovative spinal fixation system, which is currently in limited market release in the U.S. Arsenal has been designed as a comprehensive system capable of handling the most complex degenerative pathologies from T1 to the pelvis. During exhibit hours, the Company will be demonstrating the features of the Arsenal system, including the complete suite of new, ergonomically designed instrumentation in its sawbones lab at the booth.
In addition, the Company will be providing booth tours and highlighting the features and benefits of key products including: Illico MIS®, Trestle Luxe®, Alphatec Solus® and its full suite of biologics products that aid in successful spinal fusion.
Educational Symposium led by Dr. Brian Kwon: On Wednesday, November 12th at 5:30pm, Alphatec is hosting an educational symposium entitled, "The Timing of Surgery for Acute Spinal Cord Injury – Bench to Bedside Translational Perspectives." Dr. Kwon is a surgeon-scientist with advanced training in spine surgery and also a PhD in neuroscience. He is currently a Professor in the Department of Orthopaedics, University of British Columbia, and holds the Canada Research Chair in Spinal Cord Injury.
Less Invasive Solutions Course: On Thursday, November 13th at 5:00pm, Alphatec is facilitating a Less Invasive Solutions course at the Moscone Convention Center for international surgeons alongside a renowned faculty, including Dr. Joseph Aferzon, Connecticut Spine Institute, Dr. Jeffrey Bash, Middlesex Orthopedic Surgeons, Dr. Rolando Puno, Norton Leatherman Spine Center, and Dr. Blake Welling, Utah Spine Care. Course attendees will interactively rotate through our three cadaveric learning stations featuring our innovative products: Illico MIS, the Alphatec Solus Anterior Lumbar Interbody Fusion system and the Epicage Lumbar Interbody System.
"We are looking forward to collaborating with the surgeons, researchers and key thought leaders attending this year's 29th annual NASS conference and highlighting the unique value and benefits of our broad, global spinal fusion product portfolio," said Jim Corbett, President and CEO of Alphatec Spine. "This year, we are especially excited about the unique opportunity to demonstrate Arsenal, our new spinal fixation system with its innovative implants and thoughtfully-designed instrumentation to the large audience of spine care professionals attending NASS."
About Alphatec Spine
Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is a global provider of spinal fusion technologies for the treatment of spinal disorders associated with trauma, congenital deformities, disease and degeneration. The Company's mission is to combine innovative surgical solutions with world-class customer service to improve outcomes and patient quality of life. The Company and its affiliates market products in the U.S. and internationally via a direct sales force and independent distributors.
Additional information can be found at www.alphatecspine.com.
About the North American Spine Society (NASS)
The North American Spine Society is a global multidisciplinary medical society that utilizes education, research and advocacy to foster the highest quality, ethical, value- and evidence-based spine care for patients. The society is comprised of almost 9000 members worldwide from disciplines including orthopedic surgery, neurosurgery, physical medicine and rehabilitation, pain management, physical/occupational therapy, anesthesiology, radiology and other health care professionals focused on the spine.
Additional information can be found at www.nassannualmeeting.org.
Forward Looking Statements
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Alphatec Spine cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. Forward-looking statements include references to the Company's belief that certain of its products offer competitive functionalities in the marketplace. In addition, forward-looking statements include the Company's ability to develop and commercialize new products, including the products discussed in this press release. The words "believe," "will," "should," "expect," "intend," "estimate" and "anticipate," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. The important factors that could cause actual operating results to differ significantly from those expressed or implied by such forward-looking statements include, but are not limited to; the uncertainty of success in developing new products or products currently in Alphatec Spine's pipeline, including without limitation the products discussed in this press release; the uncertainties regarding the ability to successfully license or acquire new products and the commercial success of such products; failure to achieve acceptance of Alphatec Spine's products by the surgeon community, including without limitation the products discussed in this press release; Alphatec Spine's ability to develop and expand its U.S. and/or global revenues; continuation of favorable third part payor reimbursement for procedures performed using Alphatec Spine's products, including the products discussed in this press release; unanticipated expenses or liabilities or other adverse events affecting cash flow or Alphatec Spine's ability to successfully control its costs or achieve profitability; uncertainty of additional funding; Alphatec Spine's ability to compete with other competing products and with emerging new technologies; product liability exposure; an unsuccessful outcome in any material litigation in which the Company is a defendant; patent infringement claims and claims related to Alphatec Spine's intellectual property. Please refer to the risks detailed from time to time in Alphatec Spine's SEC reports, including its Annual Report Form 10-K, as well as other filings on Form 10-Q and periodic filings on Form 8-K. Alphatec Spine disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.
CONTACT: Investor/Media Contact: Christine Zedelmayer Investor Relations Alphatec Spine, Inc. (760) 494-6610 email@example.com
Source:Alphatec Holdings, Inc.